PKL CREATININA - JAFFE
Mexico·Clase I·III. DIAGNOSTIC AGENTS·AXMILAB, S.A. DE C.V.·Registered June 22, 2022PARA LA DETERMINACIÓN CUANTITATIVA IN VITRO DECREATININA EN SUERO, PLASMA U ORINA. AGENTE DEDIAGNÓSTICO IN VITRO PARA USO EXCLUSIVO DELABORATORIO CLÍNICO O DE GABINETE.
FOR QUANTITATIVE IN VITRO DETERMINATION OF CREATININE IN SERUM, PLASMA OR URINE. IN VITRO DIAGNOSTIC AGENT FOR CLINICAL LABORATORY OR CABINET USE ONLY.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA DETERMINARCREATININA
- Trade Name (English)
- CREATININE TEST
- Analysis ID
- 523R2022 SSA
- Registration Date
- June 22, 2022
- Name (Spanish)
- AXMILAB, S.A. DE C.V.
- Name (English)
- AXMILAB, S.A. DE C.V.
Access comprehensive regulatory information for PKL CREATININA - JAFFE (PKL CREATININE - JAFFE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 523R2022 SSA and manufactured by AXMILAB, S.A. DE C.V.. The device was registered on June 22, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.